Rudolf Arnold
- Neurology top 0.2%
- Neuroblastoma Research and Treatments 23
- Oncology top 0.5%
- Lung Cancer Research Studies 25
- Epidemiology top 0.2%
- Neuroendocrine Tumor Research Advances 54
- Gastroenterology top 1%
- Gastrointestinal motility and disorders 10
-
- Diabetes Treatment and Management 15
-
- Neuropeptides and Animal Physiology 22
-
- Pancreatic function and diabetes 20
- Helicobacter pylori-related gastroenterology studies 17
- Co-authors
- Burkhard GökeThomas M. GressAnja RinkeCarmen Schade‐BrittingerHans‐Helge MüllerBehnaz AminossadatiChristian ArnoldUlrich‐Frank Pape
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Rudolf Arnold
112 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Neurology 3.1k
- Oncology 4.0k
- Epidemiology 4.6k
- Gastroenterology 495
- Endocrinology, Diabetes and Metabolism 1.2k
Countries citing papers authored by Rudolf Arnold
This map shows the geographic impact of Rudolf Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Arnold more than expected).
Fields of papers citing papers by Rudolf Arnold
This network shows the impact of papers produced by Rudolf Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Arnold. The network helps show where Rudolf Arnold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rudolf Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 13 | |
| 2 | ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imagingbreakdown → | 2017 | 303 |
| 3 | 2016 | 254 | |
| 4 | Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Groupbreakdown → | 2009 | 1773 |
| 5 | 2009 | 105 | |
| 6 | 2009 | 89 | |
| 7 | 2006 | 94 | |
| 8 | 2005 | 2 | |
| 9 | 2005 | 30 | |
| 10 | Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. | 2003 | 37 |
| 11 | 2000 | 55 | |
| 12 | 1999 | 47 | |
| 13 | 1997 | 7 | |
| 14 | 1996 | 14 | |
| 15 | 1994 | 9 | |
| 16 | 1992 | 2 | |
| 17 | 1992 | 4 | |
| 18 | 1991 | 10 | |
| 19 | 1991 | 3 | |
| 20 | 1988 | 13 |
About Rudolf Arnold
Rudolf Arnold is a scholar working on Gastroenterology, Epidemiology and Neurology, having authored 112 papers that have together received 7.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (54 papers), Lung Cancer Research Studies (25 papers), Neuroblastoma Research and Treatments (23 papers), Neuropeptides and Animal Physiology (22 papers), Pancreatic function and diabetes (20 papers), Helicobacter pylori-related gastroenterology studies (17 papers), Diabetes Treatment and Management (15 papers) and Gastrointestinal motility and disorders (10 papers). The work is most often cited by research in Neurology (3.1k citations), Oncology (4.0k citations) and Epidemiology (4.6k citations). Rudolf Arnold has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Burkhard Göke, Thomas M. Gress, Anja Rinke, Carmen Schade‐Brittinger, Hans‐Helge Müller, Behnaz Aminossadati, Christian Arnold, Ulrich‐Frank Pape, Klaus‐Jochen Klose and Peter Barth. Their work appears in journals such as Gastroenterology, Neuroendocrinology, Digestion, Pancreas and Regulatory Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.